Publishing research using ab26039? Please let us know so that we can cite the reference in this datasheet.

ab26039 has been referenced in 7 publications.

  • Rasmussen RD  et al. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Mol Oncol N/A:N/A (2016). WB ; Human . PubMed: 26794465
  • Morgenroth A  et al. Hedgehog signaling sensitizes glioma stem cells to endogenous nano-irradiation. Oncotarget 5:5483-93 (2014). Flow Cyt, ICC/IF ; Human . PubMed: 24978848
  • Kuhmann C  et al. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Hum Mol Genet 23:2043-54 (2014). WB ; Human . PubMed: 24282031
  • Dean JL  et al. Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition. J Biol Chem 287:29075-87 (2012). WB ; Human . PubMed: 22733811
  • Slupianek A  et al. BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res 71:842-51 (2011). WB ; Mouse . PubMed: 21123451
  • Salton M  et al. Involvement of matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9: (2010). PubMed: 20421735
  • Chen X  et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 68:3169-77 (2008). IP ; Human . PubMed: 18451142

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"